Anabela Moreira is currently a Health Sciences PhD student at the Life and Health Sciences Research Institute (ICVS)/School of Medicine, University of Minho, and at the University College London (UCL) School of Pharmacy. She finished her Integrated Master’s in Bioengineering with a specialization in Molecular Biotechnology from the Faculty of Engineering and the Institute of Biomedical Science Abel Salazar of the University of Porto, Portugal, in 2019. Her research interests are centered around neuroscience, particularly neurodegeneration and neuronal-glial cell communication, as well as central nervous system regenerative medicine. She is experienced in cell and tissue culture, biotechnology, biomaterial fabrication and engineering, tissue engineering and regenerative medicine for various health-related applications, having published several original research and review articles in peer-reviewed journals. Her PhD project focuses on the development of advanced in vitro 3D models of Parkinson’s disease derived from induced pluripotent stem cells and on the potential therapeutic benefits of mesenchymal stem cell secretome in this neurodegenerative context.